- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
HUL gets DCGI notice over misleading Immunity Boosting Hand Sanitizer ad to prevent COVID-19
New Delhi: Taking into account the violation of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945; the Drug Controller General of India (DCGI), V G Somani has issued a show-cause notice to Hindustan Unilever Limited over the "misleading" advertisement of Lifebuoy Immunity Boosting Hand Sanitizer, claiming to prevent COVID-19.
In the ad, the company claimed that Lifebuoy immunity-boosting hand sanitizer improves immunity which in turn leads to COVID-19 prevention.
According to DCGI, while the Hand Sanitizer under scanner was licensed as a cosmetic under the Drugs and Cosmetics Act, 1940, it was being advertised as a drug, which is a violation of the law.
In this view, the drug controller sought why action should not be taken against the company for the said violation.
Giving an in-depth clarification on the definition of immunity, DCGI highlighted that Section 3(b). of Drugs and Cosmetics Act 1940 says, that immunity is a condition of being able to resist a particular disease especially through preventing the development of a pathogenic microorganism or by counteracting the effects of its products, adding that HUL's claim attracts the given definition.
Also Read: HUL Shuts Haridwar Factory For Sanitization After Employees Found COVID Positive
Further, Dr V G Somani stated that Lifebuoy's ads in television and social media contain "misleading claims" of it being an "immunity booster" and that a mere application of the hand sanitizer on exposed skin gives immunity for 10 hours.
DCGI added that HUL's claim is "false" as a topical application product cannot offer or boost immunity against germs.
"Lifebuoy Immunity Boosting Hand Sanitizer contains only 1% Niacinamide. A minuscule level of Niacinamide is absorbed through the skin, which does not trigger or boost immunological response by the human body and is insufficient to make any improvement or boost immunological response in the human body to fight viruses like corona or even germs," the notice read.
"Hindustan Unilever has craftily put out a post claiming that the Lifebuoy range of products kills inactive coronavirus, which may result in misleading and incorrect assumptions. Publication of such advertisement has the potential to mislead the general public which may be against the public interest in the present prevailing situation," it added.
The FMCG giant was pulled by DCGI earlier in June for a similar violation, where, it claimed that Lifebuoy Virus Fighter soap had anti-COVID-19 therapeutic properties, instead, it is cosmetic, reports live Mint
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751